Yanick J. Crow has been selected as the 2024 ICIS-Pfizer Award for Excellence in Interferon and Cytokine Research in recognition for his groundbreaking research on Type I Interferonopathies which has revolutionized the fields of basic and clinical immunology with phenomenal clinical and biological implications. Professor Crow is recognized as one of the top three scientists in the field of human inborn errors of immunity and the founder of the rapidly growing and revolutionary field of “Type I interferonopathies,” making him a most deserving recipient for the ICIS-Pfizer Award for Excellence in Cytokine & Interferon Research.
Professor Crow will give his ICIS-Pfizer Award Presentation at Cytokines 2024 Joint Meeting KAI 2024 in the Opening Session (13:00 – 14:40) on Sunday, October 20th at the COEX Conference Center in Seoul, Korea, an “overview of the field of monogenic diseases associated with enhanced type I interferon signalling, with an emphasis on more recent points of interest”.
